Anaphylaxis to gadolinium radiocontrast: a case report and review of the literature.
Gadolinium was first introduced in 1988 for use in magnetic resonance imaging. The safety of gadolinium chelates is well established with lower frequency of adverse reactions than non-ionic iodinated contrast media; however, serious adverse reactions can occur. We report a rare case of anaphylaxis after intravenous administration of gadopentetate dimeglumine (Magnevist), used for magnetic resonance imaging.
Shepherd
Meagan
M
Internal Medcine-Pediatrics, Louisiana State University Health Sciences Center, New Orleans, USA.
Lata
Suman
S
Mani
Sandhya
S
Fiorillo
Annette
A
Kumar
Prem
P
D000707:Anaphylaxis / Q000097:blood / Q000209:etiology*; D003287:Contrast Media / Q000009:adverse effects*; D005260:Female; D019786:Gadolinium DTPA / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D053802:Tryptases / Q000097:blood
D003287:Contrast Media; D053802:Tryptases; D019786:Gadolinium DTPA